Neuropore Therapies receives 2nd grant from The Michael J. Fox Foundation for Parkinson's research!

The Michael J. Fox Foundation for Parkinson's research awarded Neuropore Therapies a second grant on its TLR2 antagonist Program for Parkinson's disease.  READ MORE:  https://www.businesswire.com/news


Be the first to comment

Or sign in with email

    Please check your e-mail for a link to activate your account.